The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival
The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
The company has highlighted setbacks in Phase II studies while outlining fresh regulatory and late-stage development plans for Fibromun and Nidlegy
The innovation leverages Mitsui Chemicals’ oxygen-permeable InnoCell cell culture plate to efficiently collect bile while reducing stress on liver cells
Low-dose radiotherapy offers immediate pain relief, quicker recovery, and better movement through a non-invasive procedure
Its a major breakthrough for women’s ovarian cancer care in Europe
The trial, dubbed MALBEC, marks the first in a broader late-phase development push for MK-8748, with a second NVAMD study expected to begin later this year
A joint position paper warns that Europe is the only major global region without a dedicated biomanufacturing initiative
The approach, which could significantly reduce the number of rats used in certain dose-range finding studies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
